PMR and Associates, LLC Presents Lasik America, Inc. Overview

PMR and Associates, LLC Presents Lasik America, Inc. Overview 
DEL MAR, CA -- (MARKET WIRE) -- 04/12/04 --  Lasik America Inc. (OTC
BB: LSIK) is a medical services company based in Albuquerque, New
Mexico. The company currently operates a Laser Surgery Eye Clinic in
Albuquerque with the capacity to perform 100 eye surgeries each week.
The surgical procedure involves using excimer lasers to treat such
common refractive visions disorders such as myopia, hyperopia and
astigmatism. Fiscal year 2003 revenues for company were approximately
$1.4 million. The center employs a team of medical professionals
including board-certified Ophthalmologists, Optometrists and a
surgical support staff providing the latest laser eye procedures to
patients throughout the metropolitan area. Our medical staff
performed over 850 laser vision correction procedures since the
company's inception in 2001. 
Lasik America Inc. has reached supplier and financings agreements to
provide excimer lasers and related equipment with DVI Financial,
Inc., Nidek, Inc., and VISX, Incorporated. Lasik America, Inc.
Management envisions future growth through the establishment of more
Lasik surgery centers and is also exploring additional opportunities
for growth in the medical arena including bio-device, development of
surgical procedures and products and development of medical treatment
centers. 
MANAGEMENT OVERVIEW 
Dr. Howard P. Silverman, Founder and CEO of Lasik America, Inc. 
Dr. Silverman is the founder, chief executive officer and chairman of
the board of Lasik America, Inc. Historically, he has been involved in
various other companies developing products and methods of delivery
from the ophthalmic industry. Such companies include Precision
Contract Lens Labs, Inc., Diversified Health Industries, Inc., Hydro
Optics, Inc., Staar Surgical Company and Vision Science, Inc. From
1991 Dr. Silverman has been actively involved in a private consulting
business designed to address the capital and corporate structural
needs of companies in the ophthalmic and vision correction
industries. In addition, from 1994 to 1997, Dr. Silverman served as
an investment banking professional at Rickel & Associates, in New
York, New York. 
Stuart Cooper, MD, Chief Ophthalmologist, Lasik America, Albuquerque
Medical Clinic 
Dr Cooper, MD was awarded a Doctor of Medicine Degree from the
University of Illinois College of Medicine, Chicago, Ill. in 1969. He
completed his residency in Ophthalmology in 1973 at the prestigious
Cleveland Clinic in Pittsburgh, PA. Dr. Cooper has been a practicing
Ophthalmologist for over 30 years and has completed over 8,000 Lasik
procedures. Dr. Cooper is a board-certified in Ophthalmology and has
been involved in instructing new physicians, technicians and
assistants in all aspects of his specialty. Dr. Cooper has been the
Chief Ophthalmologist at the Lasik America, Inc. Albuquerque Clinic
since it opened in 2001. 
Robert S. Helmer, COO, Albuquerque Medical Center 
Mr. Helmer has been chief operating officer of the Lasik America
Inc.'s Albuquerque, New Mexico center since operations began in May
2001. Mr. Helmer also served as the clinical support manager from
October 1998 to April 2001 for TrueVision International, Inc., an eye
vision corrective surgical clinic in Albuquerque, New Mexico. Mr.
Helmer is a graduate physician and surgical assistant with 30 years
of medical experience in emergency medicine, laser medicine,
dermatology, cosmetic surgery and hair transplant surgery. Mr. Helmer
has been a certified ophthalmic laser technician since September 1998
and a certified microkeratome technician since June 1999. Mr. Helmer
received his associate of applied science degrees as a physician's
assistant and surgical assistant in 1974 from the Cincinnati
Technical College. He is a member of the American Academy of
Physicians Assistants. 
THE TECHNOLOGY 
LASIK stands for Laser-Assisted In Situ Keratomileusis and is a
procedure that permanently changes the shape of the cornea, the clear
covering of the front of the eye, using an excimer laser. A
instrument, called a microkeratome, is used to cut a flap in the
cornea. A hinge is left at one end of this flap. The flap is folded
back revealing the stroma, the middle section of the cornea. Pulses
from a computer-controlled laser vaporize a portion of the stroma and
the flap is replaced. 
The cornea is a part of the eye that helps focus light to create an
image on the retina. It works in much the same way that the lens of a
camera focuses light to create an image on film. The bending and
focusing of light is also known as refraction. Usually the shape of
the cornea and the eye are not perfect and the image on the retina is
out-of-focus (blurred) or distorted. These imperfections in the
focusing power of the eye are called refractive errors. There are
three primary types of refractive errors: myopia, hyperopia and
astigmatism. Persons with myopia, or nearsightedness, have more
difficulty seeing distant objects as clearly as near objects. Persons
with hyperopia, or farsightedness, have more difficulty seeing near
objects as clearly as distant objects. Astigmatism is a distortion of
the image on the retina caused by irregularities in the cornea or lens
of the eye. Combinations of myopia and astigmatism or hyperopia and
astigmatism are common. Glasses or contact lenses are designed to
compensate for the eye's imperfections. Surgical procedures aimed at
improving the focusing power of the eye are called refractive
surgery. In LASIK surgery, precise and controlled removal of corneal
tissue by a special laser reshapes the cornea changing its focusing
power. 
Other types of refractive surgery 
Radial Keratotomy or RK and Photorefractive Keratectomy or PRK are
other refractive surgeries used to reshape the cornea. In RK, a very
sharp knife is used to cut slits in the cornea changing its shape.
PRK was the first surgical procedure developed to reshape the cornea,
by sculpting, using a laser. Later, LASIK was developed. The same
type of laser is used for LASIK and PRK. Often the exact same laser
is used for the two types of surgery. The major difference between
the two surgeries is the way that the stroma, the middle layer of the
cornea, is exposed before it is vaporized with the laser. In PRK, the
top layer of the cornea, called the epithelium, is scraped away to
expose the stromal layer underneath. In LASIK, a flap is cut in the
stromal layer and the flap is folded back. 
Another type of refractive surgery is thermokeratoplasty in which
heat is used to reshape the cornea. The source of the heat can be a
laser, but it is a different kind of laser than is used for LASIK and
PRK. Other refractive devices include corneal ring segments that are
inserted into the stroma and special contact lenses that temporarily
reshape the cornea (orthokeratology). 
The Role of FDA 
In the United States, the Food and Drug Administration (FDA)
regulates the sale of medical devices such as the lasers used for
LASIK. Before a medical device can be legally sold in the U.S., the
person or company that wants to sell the device must seek approval
from the FDA. To gain approval, they must present evidence that the
device is reasonably safe and effective for a particular use, the
"indication." Once the FDA has approved a medical device, a doctor
may decide to use that device for other indications if the doctor
feels it is in the best interest of a patient. The use of an approved
device for other than its FDA-approved indication is called
"off-label use." The FDA does not regulate off-label use or the
practice of medicine. 
THE LASIK INDUSTRY 
In 2002 refractive surgery represented a $475 million market. The
annual number of procedures increased dramatically during the 1990's
reaching a peak of 1.4 million in 2000. Recently the number of
procedure have stabilized but industry analysts project strong future
growth going forward. Even though refractive surgery procedures, and
LASIK in particular, have declined in the past several years along
with the economy, the pool of potential candidates is large. Industry
consultant MarketScope estimates that approximately 50 million
Americans (100 million procedures) are candidates for laser vision
correction (LVC). The American Academy of Ophthalmology estimates
that more than 63 million people in the U.S. are candidates for some
type of refractive surgery. 
In 2001, only 4% of eligible patients had received laser vision
correction. Today, penetration is around 5%. Analysts forecast modest
growth from about 1.4 million procedures in 2003 to 1.5 million in
2004. However, longer-term, peak annual procedures are forecasted to
be approximately 2.5 million procedures. 
Improvements in technology, such as custom LASIK, hold the promise of
re-building the sector, with MarketScope forecasting procedure growth
of around 10% in the latter half of 2003. 
CONCLUSION 
Lasik America, Inc. is well positioned for growth into 2004 and
beyond. Its core New Mexico facility generated revenues in excess of
$1.4 million in 2003 and provides an excellent foundation to base the
company's future expansion. A seasoned, professional management team
is in place to guide growth. Industry analysts have indicated that
the corrective surgery industry sector has excellent growth potential
and many markets in the US are significantly underserved. Lasik
America, Inc. is uniquely situated to capitalize on this situation
and management looks forward to successful implementation of growth
initiatives. 
Forward-Looking Statements 
The Private Securities Litigation Reform Act of 1995 provides a safe
harbor for forward-looking information made on the company's behalf.
All statements, other than statements of historical facts which
address the company's expectations of sources of capital or which
express the company's expectation for the future with respect to
financial performance or operating strategies, can be identified as
forward-looking statements. Such statements made by the company are
based on knowledge of the environment in which it operates, but
because of the factors previously listed, as well as other factors
beyond the control of the company, actual results may differ
materially from the expectations expressed in the forward-looking
statements. 
For further information, please contact:
Patrick Rost
President
PMR and Associates, LLC
858-350-0409
Email: PMRandCO@aol.com
 Provider ID: 04065654
 
 
Press spacebar to pause and continue. Press esc to stop.